The second French center has now started active enrolment in the
@FAVORIIITrial! Congrats to
@juliendjdj and his team at Institut Arnault Tzcank in Nice for enrolling their first two FAVOR III patients this week. Many thanks for your contribution on
#QFR vs FFR!